Reversible Mild Cognitive Impairment: The Role of Comorbidities at Baseline Evaluation

Journal of Alzheimer's Disease : JAD
Giulia GrandeClaudio Mariani

Abstract

The prognostic value of mild cognitive impairment (MCI) is being questioned, with some MCI subjects reverting to normal cognition (NC). The reversion rate varies mostly depending on the study design, the setting, and both MCI and NC definitions. Previous studies have focused on the profile of subjects who revert to NC, but the role of comorbidities has not been entirely investigated. We aimed to evaluate the proportion of MCI subjects who revert to NC in a memory clinic context, focusing on the role of comorbidities. Between 2004 and 2013, 374 MCI subjects were recruited. During a mean time of 32 ± 25.5 months, 21 subjects (5.6%) reverted to NC. Subjects who reverted to NC were younger (p = 0.0001), more educated (p = 0.0001), had a better global cognition (p = 0.0001), as assessed by the Mini-Mental State Examination (MMSE) and suffered from more comorbidities (p = 0.002), as assessed by Cumulative Illness Rating Scale (CIRS) than those who developed dementia. The Cox Regression Model, constructed to adjust for the confounders, showed that the higher were the MMSE (HR = 1.83, CI 95%: 1.07-3.11) and the CIRS score (HR = 1.3, CI 95% 0.88-1.92) at baseline, the higher was the probability of returning to NC than developing dementi...Continue Reading

References

Nov 1, 1975·Journal of Psychiatric Research·M F FolsteinP R McHugh
Aug 1, 1989·Journal of the American Geriatrics Society·T SunderlandJ H Grafman
Jun 1, 1982·The British Journal of Psychiatry : the Journal of Mental Science·C P HughesR L Martin
Aug 1, 1996·Italian Journal of Neurological Sciences·A R GiovagnoliE Capitani
Apr 6, 1999·Archives of Neurology·R C PetersenE Kokmen
Apr 27, 2002·Neurological Sciences : Official Journal of the Italian Neurological Society and of the Italian Society of Clinical Neurophysiology·P CaffarraA Venneri
Sep 21, 1963·JAMA : the Journal of the American Medical Association·S KATZM W JAFFE
May 26, 2004·Lancet Neurology·Laura FratiglioniBengt Winblad
Jul 14, 2004·Neurology·Mary GanguliSteven T DeKosky
May 24, 2005·Dementia and Geriatric Cognitive Disorders·J G E JanzingP Eling
Jul 5, 2005·Neurological Sciences : Official Journal of the Italian Neurological Society and of the Italian Society of Clinical Neurophysiology·I AppollonioP Nichelli
Sep 27, 2005·Journal of Pain and Symptom Management·David B BekelmanPeter V Rabins
Oct 21, 2005·Neurology·I G McKeithUNKNOWN Consortium on DLB
Apr 14, 2007·American Journal of Epidemiology·Suzanne L TyasRichard J Kryscio
Jun 2, 2007·Movement Disorders : Official Journal of the Movement Disorder Society·Murat EmreBruno Dubois
Sep 6, 2007·Neuropsychology·Roberta PerriUNKNOWN Early Diagnosis Group of the Italian Interdisciplinary Network on Alzheimer's Disease
Sep 25, 2008·Journal of the American Geriatrics Society·Fabio SalviPaolo Dessì-Fulgheri
Jun 23, 2009·Journal of Alzheimer's Disease : JAD·Roberto MonasteroRosolino Camarda
Jul 1, 2009·BMJ : British Medical Journal·Jonathan A C SterneJames R Carpenter
Dec 8, 2009·Journal of Neurology, Neurosurgery, and Psychiatry·Arto NordlundAnders Wallin
Feb 26, 2010·Neurological Sciences : Official Journal of the Italian Neurological Society and of the Italian Society of Clinical Neurophysiology·Roberto GallassiLuisa Sambati
May 1, 1996·European Journal of Neurology : the Official Journal of the European Federation of Neurological Societies·E MagniM Trabucchi
Jun 15, 2011·Archives of Neurology·Mary GanguliRonald C Petersen
Jun 5, 2012·Frontiers in Neurology·Emilia Sforza, Frédéric Roche
Feb 1, 2013·Chest·Sylvia VilleneuveJean-François Gagnon
May 8, 2013·Chest·Mario Francesco DamianiOnofrio Resta
May 8, 2013·Chest·Sylvia VilleneuveJean-François Gagnon
Jul 26, 2013·Dementia and Geriatric Cognitive Disorders Extra·Ilaria BizzozeroErminio Capitani
Jul 16, 2014·Journal of Alzheimer's Disease : JAD·Stefan Van der MusseleSebastiaan Engelborghs
Sep 5, 2014·Current Opinion in Psychiatry·Adam P SpiraKristine Yaffe
Feb 24, 2015·The American Journal of Psychiatry·Claudia CooperGill Livingston
Mar 24, 2015·Alzheimer's Research & Therapy·James W Dodd

❮ Previous
Next ❯

Citations

Aug 10, 2016·Journal of the American Medical Directors Association·Marco CanevelliNicola Vanacore
Mar 23, 2017·Cognitive and Behavioral Neurology : Official Journal of the Society for Behavioral and Cognitive Neurology·Matthew A ClemFu L Woon
May 10, 2018·Journal of Geriatric Psychiatry and Neurology·Giulia GrandeDebora Rizzuto
Jun 11, 2019·International Journal of Geriatric Psychiatry·HuiPing XueYongBing Liu
Jan 9, 2020·Alzheimer's & Dementia : the Journal of the Alzheimer's Association·Giulia GrandeLaura Fratiglioni
Feb 28, 2020·International Journal of Geriatric Psychiatry·Jemima DooleyRose McCabe
Aug 4, 2020·Journal of Alzheimer's Disease : JAD·Almudena JunqueraSara Fernández-Guinea
Jul 31, 2021·The Journals of Gerontology. Series A, Biological Sciences and Medical Sciences·Lori L Beason-HeldSusan M Resnick

❮ Previous
Next ❯

Related Concepts

Trending Feeds

COVID-19

Coronaviruses encompass a large family of viruses that cause the common cold as well as more serious diseases, such as the ongoing outbreak of coronavirus disease 2019 (COVID-19; formally known as 2019-nCoV). Coronaviruses can spread from animals to humans; symptoms include fever, cough, shortness of breath, and breathing difficulties; in more severe cases, infection can lead to death. This feed covers recent research on COVID-19.

Blastomycosis

Blastomycosis fungal infections spread through inhaling Blastomyces dermatitidis spores. Discover the latest research on blastomycosis fungal infections here.

Nuclear Pore Complex in ALS/FTD

Alterations in nucleocytoplasmic transport, controlled by the nuclear pore complex, may be involved in the pathomechanism underlying multiple neurodegenerative diseases including Amyotrophic Lateral Sclerosis and Frontotemporal Dementia. Here is the latest research on the nuclear pore complex in ALS and FTD.

Applications of Molecular Barcoding

The concept of molecular barcoding is that each original DNA or RNA molecule is attached to a unique sequence barcode. Sequence reads having different barcodes represent different original molecules, while sequence reads having the same barcode are results of PCR duplication from one original molecule. Discover the latest research on molecular barcoding here.

Chronic Fatigue Syndrome

Chronic fatigue syndrome is a disease characterized by unexplained disabling fatigue; the pathology of which is incompletely understood. Discover the latest research on chronic fatigue syndrome here.

Evolution of Pluripotency

Pluripotency refers to the ability of a cell to develop into three primary germ cell layers of the embryo. This feed focuses on the mechanisms that underlie the evolution of pluripotency. Here is the latest research.

Position Effect Variegation

Position Effect Variagation occurs when a gene is inactivated due to its positioning near heterochromatic regions within a chromosome. Discover the latest research on Position Effect Variagation here.

STING Receptor Agonists

Stimulator of IFN genes (STING) are a group of transmembrane proteins that are involved in the induction of type I interferon that is important in the innate immune response. The stimulation of STING has been an active area of research in the treatment of cancer and infectious diseases. Here is the latest research on STING receptor agonists.

Microbicide

Microbicides are products that can be applied to vaginal or rectal mucosal surfaces with the goal of preventing, or at least significantly reducing, the transmission of sexually transmitted infections. Here is the latest research on microbicides.